Clinical trials
Bipolar Disorder I or II clinical trials
Below are recruiting bipolar disorder i or ii clinical trials, each written for real people, not researchers. We’re tracking 2,350 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07632248Recruiting
Digital Game for Early Eating Disorder Prevention
This study tests FlexED, a smartphone game designed to help young women who are worried about their weight and showing early signs of eating disorder behaviors—like extreme dieting, binge eating, or purging—before these behaviors become a full disorder. The goal is to see if this fun, interactive approach can help prevent the condition from getting worse.
Durham, North CarolinaAges 15–25 - NCT07633080Recruiting
Magnesium supplement added to antidepressants for depression
This study tests whether adding magnesium bisglycinate (a mineral supplement) to your current antidepressant medication can help improve depression symptoms. Researchers want to see if this combination works better than antidepressant alone.
Bhubaneswar, OdishaAges 18–65 - NCT07621237RecruitingPhase 2
TNX-102 SL for Major Depressive Disorder
This study tests whether a new medication called TNX-102 SL can reduce depression symptoms better than a placebo (inactive pill). You'll take the medication daily and have regular check-ins to see how you're doing.
Phoenix, ArizonaAges 18 years+ - NCT06567145Recruiting
Group therapy for self-stigma in mental health
This study tests a group therapy program designed to help people with mental health conditions reduce the shame and stigma they feel about their illness. It takes place in northeastern Italy and is for people who are stable on their current medications.
VeronaAges 18 years+ - NCT07612631RecruitingEarly Phase 1
Brain imaging study of alcohol and stress response
This research uses brain imaging to understand how two brain systems—one involved in stress and one involved in reward—interact in people with alcohol use disorder. The goal is to find new ways to help people reduce heavy drinking.
Pittsburgh, PennsylvaniaAges 18–55 - NCT06713161Recruiting
New dye to spot breast cancer during surgery
This study tests a special dye that helps surgeons see breast cancer tissue and nearby lymph nodes more clearly during surgery. The goal is to make sure all cancer is removed while sparing healthy tissue.
Kunming, YunnanAges 18–75 - NCT07587112Recruiting
TMS treatment for OCD: brain imaging study
This study tests whether repetitive transcranial magnetic stimulation (rTMS) can help people with OCD. You will get rTMS while having brain scans (PET and MRI) to see how it affects your symptoms. It's a chance to learn more about your OCD and possibly find relief.
TaipeiAges 18–65 - NCT07592689RecruitingPhase 3
DT120 Treatment for Major Depression
This study tests whether a new medication called DT120 can help people with moderate-to-severe depression feel better. You'd take the medication for several weeks while doctors track your mood and symptoms.
Little Rock, ArkansasAges 18–74 - NCT07590180Recruiting
Internet Gaming Habits and Brain Chemistry in Young Teens
This study looks at how excessive video gaming affects the brains and behavior of children ages 10–14. Researchers will compare children who game heavily with those who don't, measuring brain chemicals and decision-making patterns to understand why some kids struggle to control their gaming.
Istanbul, BakirkoyAges 10–14 - NCT07579897Recruiting
Group vs. Individual Therapy for Excessive Worry
This study tests whether therapy for generalized anxiety disorder (constant, hard-to-control worry) works better when done in a group or one-on-one. The therapy teaches you how to think differently about your worries to reduce anxiety.
Kristiansand, AgderAges 18 years+ - NCT07579494Recruiting
Brain Stimulation for Autism Spectrum Disorder Symptoms
This study tests whether a type of magnetic brain stimulation can help reduce autism symptoms and improve thinking skills in young people aged 8–30 with autism. Researchers will measure changes in symptoms, brain function, and brain scans over time.
TaoyuanAges 8–30 - NCT07580183Recruiting
Memory and Brain Function in Epilepsy Surgery
This study examines how the brain recognizes spatial scenes (like rooms or landscapes) in people with epilepsy who may have surgery. Researchers want to understand memory patterns before and after surgery to help predict outcomes.
Sacramento, CaliforniaAges 18–55 - NCT07573176RecruitingPhase 3
Seltorexant for Depression in Adults and Older Adults
This study tests a new medication called seltorexant as a standalone treatment for major depression. The trial is for adults and older adults who have depression that hasn't improved with other antidepressants or who haven't tried them yet.
Bryant, ArkansasAges 18–74 - NCT07573488Recruiting
Sleep, Stress, and Migraine: Observation and Training Study
This study explores how sleep and stress affect migraine headaches and tests whether improving sleep habits can help reduce migraines. You'll be observed and taught strategies over several months while researchers track your headaches and sleep patterns.
ZurichAges 18–65 - NCT07576686Recruiting
AI-assisted therapy for depression and anxiety
This trial tests a computer-guided cognitive behavioral therapy (CBT)—a proven talk therapy approach—to help treat mild depression and anxiety. The program runs for 10 weeks with weekly sessions, and AI helps guide your therapist or the process itself.
NišAges 18 years+ - NCT06314776Recruiting
Vibration therapy for walking in children with cerebral palsy
This study tests whether a special vibrating platform can help improve walking in children with cerebral palsy. It may help strengthen muscles and coordination.
AlmeríaAges 2–11 - NCT07559500RecruitingPhase 1
Study of tirzepatide for alcohol use disorder
This trial tests if tirzepatide, a diabetes drug, affects brain chemistry linked to alcohol use. Researchers want to see if it can help people with mild-to-moderate alcohol use disorder who also have tried stimulants.
Bethesda, MarylandAges 21–65 - NCT07554846RecruitingPhase 3
Comparing immunotherapy before, during, or after surgery for early-stage lung cancer
This trial compares giving immunotherapy at different times around surgery for stage II-IIIA non-small cell lung cancer. The goal is to find the best time to use this treatment to improve outcomes.
ShanghaiAges 18–75 - NCT06739928RecruitingPhase 2
Irinotecan liposome with immunotherapy for extensive-stage small cell lung cancer
This trial tests a combination of irinotecan liposome (a chemotherapy) or etoposide with adebrelimab (an immunotherapy) and carboplatin for people with extensive-stage small cell lung cancer who haven't had prior treatment. It aims to see if these combinations are safe and effective.
Guangzhou, GuangzhouAges 18–70 - NCT05520398Recruiting
Brain-targeting study of why OCD treatments may fail
This study looks at brain signals to understand why OCD treatments may not work for some people. If you have OCD and are about to start OCD therapy, you may be invited to take part.
LondonAges 18–55 - NCT07532395Recruiting
CrossFit Training to Help Preschoolers With Autism Get School Ready
This study tests whether a special CrossFit-based exercise program can help preschool children with autism spectrum disorder (autism) improve their physical skills, behavior, and readiness for school. The program combines structured fitness activities designed for young children with autism.
Fuzhou, FujianAges 3–6 - NCT07518056Recruiting
Smartphone Use, Stress, Body Image and Food Habits Study
This research explores whether heavy smartphone use is linked to stress, how you feel about your body, and eating habits. Understanding these connections may help develop better support for students struggling with these issues.
Istanbul, beşiktaşAges 18–30 - NCT07523048RecruitingPhase 2
Dextromethorphan-Bupropion for Moderate-to-Severe Depression
This study tests a combination medication (dextromethorphan plus bupropion) to see how it affects brain activity in people with moderate-to-severe depression. Researchers use brain imaging (fMRI) to understand how the drug works and whether it may help relieve depression symptoms.
Toronto, OntarioAges 18–65 - NCT06611592RecruitingPhase 2
Pramipexole for hard-to-treat OCD
This study tests if pramipexole can help people whose OCD hasn't improved with standard treatments like SSRIs or certain antipsychotics. You might qualify if standard therapies haven't worked for you.
BragaAges 18–64
Hear when a new Bipolar Disorder I or II trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for bipolar disorder i or ii?
- Yes. Clin2 currently lists 2,350 recruiting bipolar disorder i or ii studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a bipolar disorder i or ii trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a bipolar disorder i or ii trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.